Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) dropped 1% on Tuesday . The stock traded as low as GBX 10 ($0.13) and last traded at GBX 10 ($0.13). Approximately 560,198 shares traded hands during mid-day trading, an increase of 315% from the average daily volume of 134,951 shares. The stock had previously closed at GBX 10.10 ($0.14).
Tissue Regenix Group Price Performance
The stock has a market capitalization of £6.36 million, a P/E ratio of -467.54 and a beta of 1.61. The company has a debt-to-equity ratio of 31.16, a quick ratio of 2.36 and a current ratio of 4.03. The stock has a 50-day simple moving average of GBX 26.52 and a 200 day simple moving average of GBX 30.70.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Stories
- Five stocks we like better than Tissue Regenix Group
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 REITs to Watch as Rate Cuts Ignite a Real Estate Super Cycle
- How to Plot Fibonacci Price Inflection Levels
- 2 Defense Stocks Riding 2025’s Massive Momentum Wave
- Do ETFs Pay Dividends? What You Need to Know
- TrumpRx Brings Pfizer Into the Green—Is It a Buy?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
